BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM267870'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase BTK


(Homo sapiens (Human))
BDBM267870
PNG
(4-(8-amino-3-{(3R)-1-[(3-methyloxetan-3-yl)carbony...)
Show SMILES CC1(COC1)C(=O)N1CCC[C@H](C1)c1nc(-c2ccc(cc2F)C(=O)Nc2cc(OC3CC3)ccn2)c2c(N)nccn12 |r|
Show InChI InChI=1S/C31H32FN7O4/c1-31(16-42-17-31)30(41)38-11-2-3-19(15-38)28-37-25(26-27(33)35-10-12-39(26)28)22-7-4-18(13-23(22)32)29(40)36-24-14-21(8-9-34-24)43-20-5-6-20/h4,7-10,12-14,19-20H,2-3,5-6,11,15-17H2,1H3,(H2,33,35)(H,34,36,40)/t19-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.520n/an/an/an/an/an/a


TBA

Assay Description
Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide a...


Citation and Details

Article DOI: 10.1021/acsmedchemlett.5b00463
BindingDB Entry DOI: 10.7270/Q25B065B
More data for this
Ligand-Target Pair
Tyrosine-protein kinase BTK


(Homo sapiens (Human))
BDBM267870
PNG
(4-(8-amino-3-{(3R)-1-[(3-methyloxetan-3-yl)carbony...)
Show SMILES CC1(COC1)C(=O)N1CCC[C@H](C1)c1nc(-c2ccc(cc2F)C(=O)Nc2cc(OC3CC3)ccn2)c2c(N)nccn12 |r|
Show InChI InChI=1S/C31H32FN7O4/c1-31(16-42-17-31)30(41)38-11-2-3-19(15-38)28-37-25(26-27(33)35-10-12-39(26)28)22-7-4-18(13-23(22)32)29(40)36-24-14-21(8-9-34-24)43-20-5-6-20/h4,7-10,12-14,19-20H,2-3,5-6,11,15-17H2,1H3,(H2,33,35)(H,34,36,40)/t19-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



MERCK SHARP & DOHME CORP.; MERCK SHARP & DOHME B.V.

US Patent


Assay Description
BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...


US Patent US9718828 (2017)


BindingDB Entry DOI: 10.7270/Q2H9977T
More data for this
Ligand-Target Pair
Tyrosine-protein kinase BTK


(Homo sapiens (Human))
BDBM267870
PNG
(4-(8-amino-3-{(3R)-1-[(3-methyloxetan-3-yl)carbony...)
Show SMILES CC1(COC1)C(=O)N1CCC[C@H](C1)c1nc(-c2ccc(cc2F)C(=O)Nc2cc(OC3CC3)ccn2)c2c(N)nccn12 |r|
Show InChI InChI=1S/C31H32FN7O4/c1-31(16-42-17-31)30(41)38-11-2-3-19(15-38)28-37-25(26-27(33)35-10-12-39(26)28)22-7-4-18(13-23(22)32)29(40)36-24-14-21(8-9-34-24)43-20-5-6-20/h4,7-10,12-14,19-20H,2-3,5-6,11,15-17H2,1H3,(H2,33,35)(H,34,36,40)/t19-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 18n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-hu...


Citation and Details

Article DOI: 10.1021/acsmedchemlett.5b00463
BindingDB Entry DOI: 10.7270/Q25B065B
More data for this
Ligand-Target Pair